Racial/Ethnic-Specific Differences in the Effects of Inhaled Corticosteroid Use on Bronchodilator Response in Patients With Asthma
- PMID: 31209858
- PMCID: PMC6778006
- DOI: 10.1002/cpt.1555
Racial/Ethnic-Specific Differences in the Effects of Inhaled Corticosteroid Use on Bronchodilator Response in Patients With Asthma
Abstract
American Thoracic Society guidelines recommend inhaled corticosteroid (ICS) therapy, plus a short-acting bronchodilator, in patients with persistent asthma. However, few prior studies have examined the efficacy of this combination in children of all racial/ethnic groups. We evaluated the association between ICS use and bronchodilator response (BDR) in three pediatric populations with persistent asthma (656 African American, 916 Puerto Rican, and 398 Mexican American children). The association was assessed using multivariable quantile regression. After adjusting for baseline forced expiratory volume in one second and use of controller medications, ICS use was significantly associated with increased BDR only among Mexican Americans (1.56%, P = 0.028) but not African Americans (0.49%, P = 0.426) or Puerto Ricans (0.16%, P = 0.813). Our results demonstrate that ICS augmentation is disproportionate across racial/ethnic groups, where improved BDR is observed in Mexican Americans only. This study highlights the complexities of treating asthma in children, and reinforces the importance of investigating the influence of race/ethnicity on pharmacological response.
© 2019 The Authors Clinical Pharmacology & Therapeutics © 2019 American Society for Clinical Pharmacology and Therapeutics.
Conflict of interest statement
Conflict of Interest:
The authors declared no competing interests for this work.
Similar articles
-
Inhaled corticosteroids and augmented bronchodilator responsiveness in Latino and African American asthmatic patients.Ann Allergy Asthma Immunol. 2008 Jun;100(6):551-7. doi: 10.1016/S1081-1206(10)60055-5. Ann Allergy Asthma Immunol. 2008. PMID: 18592818
-
Ethnic-specific differences in bronchodilator responsiveness among African Americans, Puerto Ricans, and Mexicans with asthma.J Asthma. 2007 Oct;44(8):639-48. doi: 10.1080/02770900701554441. J Asthma. 2007. PMID: 17943575
-
Augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Rican and Mexican children.Ann Allergy Asthma Immunol. 2009 Jun;102(6):510-7. doi: 10.1016/S1081-1206(10)60126-3. Ann Allergy Asthma Immunol. 2009. PMID: 19558011 Free PMC article.
-
Finding the correct inhaled corticosteroid dose in asthma.Postgrad Med. 2005 May;117(5):21-4. doi: 10.3810/pgm.2005.05.1626. Postgrad Med. 2005. PMID: 15948364 Review. No abstract available.
-
Single Nucleotide Polymorphisms (SNPs) in PRKG1 & SPATA13-AS1 are associated with bronchodilator response: a pilot study during acute asthma exacerbations in African American children.Pharmacogenet Genomics. 2021 Sep 1;31(7):146-154. doi: 10.1097/FPC.0000000000000434. Pharmacogenet Genomics. 2021. PMID: 33851947 Free PMC article. Review.
Cited by
-
Neighborhood Deprivation and Crime on Asthma Exacerbations and Utilization in Mild Adult Asthma.J Allergy Clin Immunol Pract. 2024 Nov;12(11):2966-2974.e11. doi: 10.1016/j.jaip.2024.08.014. Epub 2024 Aug 13. J Allergy Clin Immunol Pract. 2024. PMID: 39147276
-
Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia - a post hoc evaluation of the COVID STEROID 2 trial.Lancet Reg Health Southeast Asia. 2023 Oct 4;20:100293. doi: 10.1016/j.lansea.2023.100293. eCollection 2024 Jan. Lancet Reg Health Southeast Asia. 2023. PMID: 38234702 Free PMC article.
-
Dupilumab and tezepelumab in severe refractory asthma: new opportunities.Ther Adv Chronic Dis. 2022 May 25;13:20406223221097327. doi: 10.1177/20406223221097327. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35655942 Free PMC article. Review.
-
Genetic Determinants of Poor Response to Treatment in Severe Asthma.Int J Mol Sci. 2021 Apr 20;22(8):4251. doi: 10.3390/ijms22084251. Int J Mol Sci. 2021. PMID: 33923891 Free PMC article. Review.
-
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs.Nat Rev Drug Discov. 2023 Sep;22(9):743-767. doi: 10.1038/s41573-023-00750-1. Epub 2023 Aug 1. Nat Rev Drug Discov. 2023. PMID: 37528191 Review.
References
-
- World Health Organization. Asthma <http://www.who.int/mediacentre/factsheets/fs307/en/> (2017). Accessed July 24 2018.
-
- Akinbami LJ et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS Data Brief, 1–8 (2012). - PubMed
-
- Moorman JE et al. National surveillance of asthma: United States, 2001–2010. Vital Health Stat 3, 1–58 (2012). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 ES015794/ES/NIEHS NIH HHS/United States
- R01 HL141992/HL/NHLBI NIH HHS/United States
- R01 GM075316/GM/NIGMS NIH HHS/United States
- K01 HL140218/HL/NHLBI NIH HHS/United States
- R01 HL128439/HL/NHLBI NIH HHS/United States
- R01 HL135156/HL/NHLBI NIH HHS/United States
- T32 GM007546/GM/NIGMS NIH HHS/United States
- R01 HL117004/HL/NHLBI NIH HHS/United States
- P60 MD006902/MD/NIMHD NIH HHS/United States
- R21 ES024844/ES/NIEHS NIH HHS/United States
- L40 HL143533/HL/NHLBI NIH HHS/United States
- RL5 GM118984/GM/NIGMS NIH HHS/United States
- R01 MD010443/MD/NIMHD NIH HHS/United States